Skip to main content

Market Overview

A 'Pivotal Binary Event' Is Coming For Healthcare Stocks

Share:
A 'Pivotal Binary Event' Is Coming For Healthcare Stocks

In a report published Thursday, Leerink analyst Ana Gupte, Ph.D. detailed a conference call with MEDACorp specialists following the Supreme Court's oral arguments on the challenge to the Federal Exchange Subsidies.

Speaking to Gupte included a former D-House Representative as well as an Insurance Commissioner, the other a Supreme Court specialist who was live in the courtroom during the arguments.

"The odds of a favorable outcome for the Government look better than before the hearings, though still viewed by our panelists as a 50:50 tossup with Chief Justice Roberts and Justice Kennedy as swing votes," Gupte wrote. "In the event the challenge to the subsidies is upheld, our panelists see low odds of successful Federal legislation to re-establish subsidies, while State ideology is still the dominant limitation in adoption of workarounds."

Gupte added that while the odds of a favorable outcome for the government are higher, it is prudent to remind investors of 2012 where the final ruling did not mirror the expectations post oral arguments in March which caused the sector to give up all gains.

The analyst added that the end of June/early July ruling represents a "pivotal binary event" for the Hospital coverage, leading to a more bullish view of the group as a whole.

Company Specific Commentary

Gupte suggested that investors remain more bullish on Managed Care companies that hold much lower exposure to this "binary event" and superior near and long-term fundamentals. Among coverage, Humana Inc (NYSE: HUM) has the maximum earnings exposure to Federal Exchanges (2 percent), followed by Aetna Inc (NYSE: AET) and Centene Corp (NYSE: CNC) at 1 percent while the others have less than 1 percent exposure.

Gupte also recommended Universal Health Services, Inc. (NYSE: UHS), HCA Holdings Inc (NYSE: HCA) and Community Health Systems (NYSE: CYH) as "selective stock opportunities rated Outperform."

Latest Ratings for CNC

DateFirmActionFromTo
Feb 2022Deutsche BankMaintainsBuy
Feb 2022MizuhoMaintainsNeutral
Jan 2022BarclaysReinstatesOverweight

View More Analyst Ratings for CNC

View the Latest Analyst Ratings

 

Related Articles (CNC)

View Comments and Join the Discussion!

Posted-In: Ana Gupte Chief Justice RobertsAnalyst Color Health Care Previews Analyst Ratings Trading Ideas General Best of Benzinga

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com